Abstract
The impact of managed care has been dramatic in child psychiatric services. This paper describes the clinical evolution of child mental health services in the US in the context of managed care. The paper notes the lack of information guiding the safety and effectiveness of treatment, and the authors argue that there are both clinical and ethical reasons for managed care organizations to share data about their beneficiaries treatment outcomes in an effort to improve the safety and quality of psychiatric care to children and adolescents. The authors make recommendations for changes in public accountability and call for collaboration between all parties to occur without further delay.
Keywords: child psychiatry, child and adolescent mental health, managed care, quality of care, ethics
Current Pediatric Reviews
Title: Managed Health Care and Child Mental Health Services: Where Is Horton to Hear the Whos?
Volume: 1 Issue: 1
Author(s): Michael S. Jellinek, Melissa E. Abraham, Anna C. Muriel and Susan Swick
Affiliation:
Keywords: child psychiatry, child and adolescent mental health, managed care, quality of care, ethics
Abstract: The impact of managed care has been dramatic in child psychiatric services. This paper describes the clinical evolution of child mental health services in the US in the context of managed care. The paper notes the lack of information guiding the safety and effectiveness of treatment, and the authors argue that there are both clinical and ethical reasons for managed care organizations to share data about their beneficiaries treatment outcomes in an effort to improve the safety and quality of psychiatric care to children and adolescents. The authors make recommendations for changes in public accountability and call for collaboration between all parties to occur without further delay.
Export Options
About this article
Cite this article as:
Jellinek S. Michael, Abraham E. Melissa, Muriel C. Anna and Swick Susan, Managed Health Care and Child Mental Health Services: Where Is Horton to Hear the Whos?, Current Pediatric Reviews 2005; 1(1) . https://dx.doi.org/10.2174/1573396052953507
DOI https://dx.doi.org/10.2174/1573396052953507 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Uric Acid and Hypertension
Current Pharmaceutical Design Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
Current Gene Therapy Epigenomic-Basis of Preemptive Medicine for Neurodevelopmental Disorders
Current Genomics Role of Alterations in the Apoptotic Machinery in Sensitivity of Cancer Cells to Treatment
Current Pharmaceutical Design Fibroblast Growth Factor Receptor-3 as a Therapeutic Target for Achondroplasia - Genetic Short Limbed Dwarfism
Current Drug Targets Mechlorethamine based Drug Structures for Intervention of Central Nervous System Tumors
Central Nervous System Agents in Medicinal Chemistry Genetics Talks to Epigenetics? The Interplay Between Sequence Variants and Chromatin Structure
Current Genomics Unravelling the Genetic Susceptibility to Develop Ligament and Tendon Injuries
Current Stem Cell Research & Therapy Encapsulation of Imatinib in Targeted KIT-5 Nanoparticles for Reducing its Cardiotoxicity and Hepatotoxicity
Anti-Cancer Agents in Medicinal Chemistry Rationale for Peptide and DNA Based Epitope Vaccines for Alzheimers Disease Immunotherapy
CNS & Neurological Disorders - Drug Targets Neurotuberculosis: An Overview
Central Nervous System Agents in Medicinal Chemistry Evaluation of the Effectiveness of Breastfeeding as a Factor in the Prevention of Breast Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Zebrafish as a Model System to Screen Radiation Modifiers
Current Genomics Immunomodulatory Therapy Associated to Anti-Parasite Drugs as a Way to Prevent Severe Forms of Malaria
Current Clinical Pharmacology Genetics of Serotonin Receptors and Depression: State of the Art
Current Drug Targets Diet and Metabolic Syndrome: An Overview
Current Vascular Pharmacology Editorial: The Impact of a Life Threatening Disease on the Growth and Development of the Pediatric Patient
Current Pediatric Reviews Obesity and Arterial Compliance Alterations
Current Vascular Pharmacology Flavonoids for Allergic Diseases: Present Evidence and Future Perspective
Current Pharmaceutical Design Subject Index To Volume 12
Current Pharmaceutical Design